|
| 36317680 | Rhabdomyosarcoma xenotransplants in zebrafish embryos. | Pediatr Blood Cancer | 2023 |
| 36399161 | Evaluation of functional and metabolic tumor volume using voxel-wise analysis in childhood rhabdomyosarcoma. | Pediatr Radiol | 2023 |
| 36317680 | Rhabdomyosarcoma xenotransplants in zebrafish embryos. | Pediatr Blood Cancer | 2023 |
| 37612542 | Controlled flow reduction of an iliacoportal shunt graft for portal vein arterialization in a pediatric patient. | Pediatr Radiol | 2023 |
| 37345159 | Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma. | Cancers (Basel) | 2023 |
| 36764384 | Genetic susceptibility in children, adolescents, and young adults diagnosed with soft-tissue sarcomas. | Eur J Med Genet | 2023 |
| 37612542 | Controlled flow reduction of an iliacoportal shunt graft for portal vein arterialization in a pediatric patient. | Pediatr Radiol | 2023 |
| 37345159 | Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma. | Cancers (Basel) | 2023 |
| 36399161 | Evaluation of functional and metabolic tumor volume using voxel-wise analysis in childhood rhabdomyosarcoma. | Pediatr Radiol | 2023 |
| 36764384 | Genetic susceptibility in children, adolescents, and young adults diagnosed with soft-tissue sarcomas. | Eur J Med Genet | 2023 |
| 34866327 | Combinatorial effects of azacitidine and trametinib on NRAS-mutated melanoma. | Pediatr Blood Cancer | 2022 |
| 35974385 | Genotype-phenotype associations within the Li-Fraumeni spectrum: a report from the German Registry. | J Hematol Oncol | 2022 |
| 35839732 | Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe. | Eur J Cancer | 2022 |
| 35452896 | Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis. | Eur J Cancer | 2022 |
| 36467974 | Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No.â¿¿015/074, April 2021). | Geburtshilfe Frauenheilkd | 2022 |
| 34866327 | Combinatorial effects of azacitidine and trametinib on NRAS-mutated melanoma. | Pediatr Blood Cancer | 2022 |
| 35839732 | Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe. | Eur J Cancer | 2022 |
| 35452896 | Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis. | Eur J Cancer | 2022 |
| 36467974 | Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No.â¿¿015/074, April 2021). | Geburtshilfe Frauenheilkd | 2022 |
| 35974385 | Genotype-phenotype associations within the Li-Fraumeni spectrum: a report from the German Registry. | J Hematol Oncol | 2022 |
| 32888134 | Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working Group. | Fam Cancer | 2021 |
| 33800365 | Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis. | Cancers (Basel) | 2021 |
| 34050933 | A Study of Regulatory Challenges of Pediatric Oncology Phase I/II Trial Submissions and Guidance on Protocol Development. | Clin Pharmacol Ther | 2021 |
| 33887740 | Utilization of Interdisciplinary Tumor Boards for Sarcoma Care in Germany: Results from the PROSa Study. | Oncol Res Treat | 2021 |
| 33723397 | Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis. | Br J Cancer | 2021 |
| 34187933 | Negative correlation of single-cell <i>PAX3:FOXO1</i> expression with tumorigenicity in rhabdomyosarcoma. | Life Sci Alliance | 2021 |
| 33499165 | Lack of Electron Acceptors Contributes to Redox Stress and Growth Arrest in Asparagine-Starved Sarcoma Cells. | Cancers (Basel) | 2021 |
| 34347371 | Clinical evidence for a biological effect of epigenetically active decitabine in relapsed or progressive rhabdoid tumors. | Pediatr Blood Cancer | 2021 |
| 33306276 | Pathology of childhood rhabdomyosarcoma: A consensus opinion document from the Children's Oncology Group, European Paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe. | Pediatr Blood Cancer | 2021 |
| 33181584 | In Reply: Comments About Patterns of Prior and Subsequent Neoplasms in Children and Adolescents With Soft Tissue Sarcomas. | J Pediatr Hematol Oncol | 2021 |
| 32888134 | Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working Group. | Fam Cancer | 2021 |
| 34569185 | Breast cancer characteristics and surgery among women with Li-Fraumeni syndrome in Germany-A retrospective cohort study. | Cancer Med | 2021 |
| 34373263 | The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets. | Cancer Discov | 2021 |
| 33499165 | Lack of Electron Acceptors Contributes to Redox Stress and Growth Arrest in Asparagine-Starved Sarcoma Cells. | Cancers (Basel) | 2021 |
| 33887740 | Utilization of Interdisciplinary Tumor Boards for Sarcoma Care in Germany: Results from the PROSa Study. | Oncol Res Treat | 2021 |
| 33800365 | Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis. | Cancers (Basel) | 2021 |
| 33723397 | Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis. | Br J Cancer | 2021 |
| 34569185 | Breast cancer characteristics and surgery among women with Li-Fraumeni syndrome in Germany-A retrospective cohort study. | Cancer Med | 2021 |
| 34187933 | Negative correlation of single-cell <i>PAX3:FOXO1</i> expression with tumorigenicity in rhabdomyosarcoma. | Life Sci Alliance | 2021 |
| 34347371 | Clinical evidence for a biological effect of epigenetically active decitabine in relapsed or progressive rhabdoid tumors. | Pediatr Blood Cancer | 2021 |
| 34050933 | A Study of Regulatory Challenges of Pediatric Oncology Phase I/II Trial Submissions and Guidance on Protocol Development. | Clin Pharmacol Ther | 2021 |
| 34373263 | The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets. | Cancer Discov | 2021 |
| 33306276 | Pathology of childhood rhabdomyosarcoma: A consensus opinion document from the Children's Oncology Group, European Paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe. | Pediatr Blood Cancer | 2021 |
| 33181584 | In Reply: Comments About Patterns of Prior and Subsequent Neoplasms in Children and Adolescents With Soft Tissue Sarcomas. | J Pediatr Hematol Oncol | 2021 |
| 32557628 | Cancer surveillance and distress among adult pathogenic TP53 germline variant carriers in Germany: A multicenter feasibility and acceptance survey. | Cancer | 2020 |
| 32430916 | Dermatofibrosarcoma protuberans in children and adolescents: Primary and Relapsed disease-Experience of the Cooperative Weichteilsarkomstudiengruppe (CWS). | J Surg Oncol | 2020 |
| 32238360 | Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes. | Cancer Discov | 2020 |
| 31814291 | Endothelial cell malignancies in infants, children and adolescents: Treatment results of three Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry. | Pediatr Blood Cancer | 2020 |
| 32984213 | Case Report: Hepatic Adenoma in a Child With a Congenital Extrahepatic Portosystemic Shunt. | Front Pediatr | 2020 |
| 33129040 | Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium. | Eur J Cancer | 2020 |